Table 3 Descriptive statistics for MMP-2/TIMP-2 ratio and MMP-9/TIMP-1 ratio at five (5) consecutive visits – before and after radioiodine therapy, presented with probability values (p-values) of Kruskal-Wallis’ ANOVA for repeated measures design
VISIT: | n | Mean ± SD | p-value | |
|---|---|---|---|---|
MMP-2/TIMP-2 | before radioiodine | 23 | 2.96 ± 0.54 | 0.34 |
7 days post | 21 | 2.65 ± 0.43 | ||
3 months post | 23 | 2.68 ± 0.57 | ||
6 - 8 months post | 23 | 3.00 ± 0.65 | ||
15-18 months post | 17 | 2.86 ± 0.63 | ||
MMP-9/TIMP-1 | before radioiodine | 23 | 4.16 ± 3.19 | 0.042 |
7 days post | 21 | 3.40 ± 2.06 | ||
3 months post | 23 | 3.39 ± 1.47 | ||
6 - 8 months post | 23 | 3.00 ± 1.95 | ||
15-18 months post | 17 | 2.92 ± 1.68 |